Real-time enrollment status for this locally advanced pancreatic ductal adenocarcinoma (pda) clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 10:25 PM UTC
| NCT Number | NCT06984562 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA) |
| Phase | NA |
| Target Enrollment | 16 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fox Chase Cancer Center |
| Last Updated on CT.gov | October 29, 2025 (Oct 29, 2025) |
As of July 16, 2026: Clinical trial NCT06984562 is currently recruiting participants. This na study for locally advanced pancreatic ductal adenocarcinoma (pda) is actively seeking new participants at 1 location across the United States. The study is sponsored by Fox Chase Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06984562 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06984562 was last updated Oct 29, 2025 (October 29, 2025). HelloStudys verifies this status automatically.